SlideShare una empresa de Scribd logo
1 de 20
Descargar para leer sin conexión
Screening of anticholinesterases
Presentedby:-
Kalyani thombre
Anti-cholinesterses (anti-Ches) are the agents which
 Inhibit ChE.
 Protect Ach from hydrolysis.
 Produce cholinergic effects in vivo.
 Potentiate Ach both in vivo and in vitro.
Introduction
Screening of anticholinesterases
Screening of anticholinesterases
 In vitro inhibition of acetylcholine-esterase activity in
rat striatum
 In vitro inhibition of butyrylcholine-esterase activity in
human serum
 Ex-vivo cholinesterase inhibition
 Molecular forms of acetyl-cholinesterase from Rat
Frontal Cortex and Striatum
 Release of (3H) Ach and other transmitters from Rat
Brain Slices
 (3H) Oxotremorine –M Binding in the presence and
absense of Gpp(NH)p
In vitro methods
 Stimulation of Phosphatidylinositol Turnover in Rat Brain
Slices
 (3H) N-Methylcarbamylcholine Binding to Nicotinic
Cholinergic Receptors in Rat Frontal Cortex
 Uncompetitive NMDA Receptor Antagonism
 Secreation of Nerve Growth Factor by Cultured Neurons
/Astrogial Cells
 Inhibition of RespirTORY Burst in Microglial Cells
/Macrophages
 Inhibitory Avoidance Methods
A. Step down test in mice and rats
B. Step through test in rodents
C. Uphill avoidance test in rats
D. Scopalamine-induced amnesia in mice
E. Ibotenic acid-induced impairment of memory
 Active Avoidance Tests
A. Runway avoidance in rats and mice
B. Shuttle box avoidance test(two way shuttle box)
C. Jumping avoidance in one-way shuttle box
In vivo methods
 Discrimination learning
A. Spatial habituation learning
B. Spatial discrimination test in rodents
C. Spatial learning test in the radial arm maze
D. Spatial learning test in the water maze
E. Olfactory learning in rats
 Conditioned response
A. Conditioned nictitating membrane response in rabbits
In vitro inhibition of acetylcholine-esterase activity on rat
striatum
Purpose and rationale
 The purpose of this assay is to screen drugs for inhibition of
acetylcholine-esterase activity.
 Inhibitors of this enzyme may be useful for the treatment of
Alzheimer’s disease.
 PROCEDURE
 Reagents:-1) 0.05M,phosphate buffer , PH 7.2
 A) 6.85g NaH2PO4.H2O/100ml distilled H2O
In vitro methods
c) Add a) to b)until pH reaches 7.2
d) Dilute 1:10
2.Substrate in buffer
a) 198 mg acetylthiocholine chloride(10mM)
b) Q.s.explain to 100ml with 0.05M NaH2PO4,Ph 7.2
3.DTAB in buffer
a. 19.8mg 5,5-dithiobisnitrobenzoic acid (DTAB) (0.05mM)
b. Q.s. to 100ml with 0.05M NaH2PO4,Ph 7.2
4. A 2mM stock solution of the test drug is made up in a suitable
solvent and q.s. to volume with 0.05mM DTAB. Drugs are
serially diluted (1:10) such that the final concentration is 10-4M
and screened for the activity.
 Tissue preparation
 Male wistar rats are decapitated , brains rapidly
removed,corpora striata dissected free,weighed and
homogenized in 19 volumes of 0.05M NaH2PO4,PH 7.2
using a Potter-ELVEJHEM homogeizer.
 A 25ul of aliquot of this suspension is added to 1ml of the
vehicle or various concentrations of the test drug and
reincubated for 10min at 37degree celcius.
 Assay
 Enzyme activity is measured with the Beckman DU-50
spectrophotometer.
 this method can be used for IC50determinations and for
measuring kinetic constants.
 Reagents are added to the blank and sample cuvettes as
follows:-
 Blank: 0.8ml PO4 buffer/DTAB
 0.8ml buffer/substrate
 Control: 0.8ml PO4buffer/DTAB/Enzyme
 0.8ml PO4 buffer/substrate
 Drug: 0.8ml PO4 buffer/DTAB/Drug/Enzyme
 0.8ml PO4buffer/Substrate
EVALUATION
For IC50 determinations: substrate concentration is 10mM
diluted 1:2 in an assay yeilding a final concentrationof
5mM.DTAB concentration yeilding 0.25mM final
concentration.
%inhibition= slope control-slope drug *100
slope control
PURPOSE AND RATIONALE
This assay can be used in conjunction with the acetylcholine-
esterase assay to determine the enzyme selectivity of various
cholinesterase inhibitors.
PROCEDURE
Reagents
1. 0.05M phosphate buffer,PH 7.2
a) 6.85g NaHPO4.H2O/100ml distilled H2O
b) 13.40g NaHPO4.H2O/100ml distilled H2O
c) Add (a) to (b) until PH reaches 7.2
d) Dilute 1:10
In vitro inhibition of Butyrylcholine-
Esterase Activity in Human serum
2.Substrate in buffer
a) 225.8mg s-butyrylthiocholine chloride
b) Q.s. to 100ml with 0.05M phosphate buffer,PH 7.2
3.DTAB in buffer
a) 19.8mg 5,5-dithiobisnitrobenzoic acid(0.5mM)
b) Q.s.to 100ml with 0.05M phosphate buffer,PH 7.2
4. A 2mM stock solution of the test drug is made up in a
suitable solvent and q.s. to volume with 0.5mM DTAB.
Drugs are serially diluted(1:10) such that determined from
the inhibitory activity of subsequent concentrations.
Enzyme preparation:
A vial of lyophilized human serum is reconstituted in 3ml of
distilled water.
A 25ml aliquot of this suspension is added to 1ml of the
vehicle or various concentrations of the test drug and
preincubated for 10min at 37degree cel.
 EVALUATION
 For IC50 determinations:
 Substrate concentration is 10mM diluted 1:2 in assay
yeilding final concentration of 5mM.DTAB
concentration is 0.5mM yeilding 0.25mM final
concentration.
 % inhibition = slope control-slope drug *100
slope control
 Inhibitory (passive) avoidance
• One of the most common animal tests in memory research is
the inhibition to initiate activities or learned habits.
• “Passive avoidance” is usually employed to describe
experiments in which the animal learns to avoid noxious event
by suppressing a particular behaviour.
 Step-down avoidance
Purpose and rational
When placed on an elevated platform in the centre of
rectangular compartment , it steps down almost immediately to
the floor to explore the enclosure and to approach the wall.
In vivo methods
 PROCEDURE
 it consists of three phases
 1.familirization
 2.learning
 3.retention test
 EVALUATION
 The time of descent
During the learning phase
And the time during retention test is measured.
Step-through method
PURPOSE AND RATIONALE
When placed into a brightly illuminated space connected to a dark enclosure,they
rapidly enter the dark compartment and remain there.
PROCEDURE
The test animals are placed in
The illuminated compartment
At a maximal distance from the
guillotine door,and the latency
to enter in dark comartment is
Measured.
EVALUATION
the time to step through during
the learning phase is measured
And the time during the retention
test is measured.
 Drug discovery and evaluation by wolfgang H. Vogel
2nd edition
 Screening methods in pharmacology by
N.S.Parmar,Shiv Prakash ,4th edition
REFERENCES
Screening of anticholinesterases

Más contenido relacionado

La actualidad más candente

Screening of hepatoprotective drugs
Screening of hepatoprotective drugsScreening of hepatoprotective drugs
Screening of hepatoprotective drugsDipanjaliKamthe
 
Screening of anti ulcer drugs
Screening of anti ulcer drugsScreening of anti ulcer drugs
Screening of anti ulcer drugsDr Roohana Hasan
 
Screening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugsScreening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugsAbu Sufiyan Chhipa
 
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo ModelsPreclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo ModelsChetan Prakash
 
screening method of hepatoprotective drugs.pptx
screening method of hepatoprotective drugs.pptxscreening method of hepatoprotective drugs.pptx
screening method of hepatoprotective drugs.pptxSIRAJUDDIN MOLLA
 
screening of anxiolytics
screening of anxiolyticsscreening of anxiolytics
screening of anxiolyticsSayanti Sau
 
Toxicologiocal screening methods (antiemetic drugs)
Toxicologiocal screening methods (antiemetic drugs)Toxicologiocal screening methods (antiemetic drugs)
Toxicologiocal screening methods (antiemetic drugs)APOORVA MISHRA
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methodsShobhiniChandel
 
Screening models on aphrodisiac agents
Screening models on aphrodisiac agentsScreening models on aphrodisiac agents
Screening models on aphrodisiac agentsJaineel Dharod
 
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIASCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIASreyaRathnaj
 
Preclinical screening of antiallergics
Preclinical screening of antiallergicsPreclinical screening of antiallergics
Preclinical screening of antiallergicsPrajitha p
 
screening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agentsscreening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agentsPrajitha p
 
Diuretics screening models
Diuretics screening modelsDiuretics screening models
Diuretics screening modelsJaineel Dharod
 
Anti diarrheal & laxatives
Anti diarrheal & laxativesAnti diarrheal & laxatives
Anti diarrheal & laxativesJaineel Dharod
 
Screening of antihypertensive agents
Screening of antihypertensive agentsScreening of antihypertensive agents
Screening of antihypertensive agentsKanthlal SK
 
Immunoassay of insulin (neha)
Immunoassay of insulin (neha)Immunoassay of insulin (neha)
Immunoassay of insulin (neha)ANANYAPANDEY71
 
Screening models for immunomodulator
Screening models for immunomodulatorScreening models for immunomodulator
Screening models for immunomodulatorMr. MOHD FAHAD
 

La actualidad más candente (20)

Screening of hepatoprotective drugs
Screening of hepatoprotective drugsScreening of hepatoprotective drugs
Screening of hepatoprotective drugs
 
Screening of anti ulcer drugs
Screening of anti ulcer drugsScreening of anti ulcer drugs
Screening of anti ulcer drugs
 
Screening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugsScreening of Antihyperlipidemic drugs
Screening of Antihyperlipidemic drugs
 
Screening Models of Anti-Atherosclerosis
Screening Models of Anti-AtherosclerosisScreening Models of Anti-Atherosclerosis
Screening Models of Anti-Atherosclerosis
 
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo ModelsPreclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
 
screening method of hepatoprotective drugs.pptx
screening method of hepatoprotective drugs.pptxscreening method of hepatoprotective drugs.pptx
screening method of hepatoprotective drugs.pptx
 
screening of anxiolytics
screening of anxiolyticsscreening of anxiolytics
screening of anxiolytics
 
Toxicologiocal screening methods (antiemetic drugs)
Toxicologiocal screening methods (antiemetic drugs)Toxicologiocal screening methods (antiemetic drugs)
Toxicologiocal screening methods (antiemetic drugs)
 
Hepatoprotective screening methods
Hepatoprotective screening methodsHepatoprotective screening methods
Hepatoprotective screening methods
 
Screening models on aphrodisiac agents
Screening models on aphrodisiac agentsScreening models on aphrodisiac agents
Screening models on aphrodisiac agents
 
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIASCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
 
Preclinical screening of antiallergics
Preclinical screening of antiallergicsPreclinical screening of antiallergics
Preclinical screening of antiallergics
 
screening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agentsscreening methods for anti-atherosclerotic agents
screening methods for anti-atherosclerotic agents
 
Diuretics screening models
Diuretics screening modelsDiuretics screening models
Diuretics screening models
 
Anti diarrheal & laxatives
Anti diarrheal & laxativesAnti diarrheal & laxatives
Anti diarrheal & laxatives
 
Screening of antidepressant
Screening of antidepressantScreening of antidepressant
Screening of antidepressant
 
Screening of antihypertensive agents
Screening of antihypertensive agentsScreening of antihypertensive agents
Screening of antihypertensive agents
 
Immunoassay of insulin (neha)
Immunoassay of insulin (neha)Immunoassay of insulin (neha)
Immunoassay of insulin (neha)
 
SCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGSSCREENING OF ANTI CANCER DRUGS
SCREENING OF ANTI CANCER DRUGS
 
Screening models for immunomodulator
Screening models for immunomodulatorScreening models for immunomodulator
Screening models for immunomodulator
 

Similar a Screening of anticholinesterases

PROTEOMICS -DTNB ASSAY
PROTEOMICS -DTNB ASSAYPROTEOMICS -DTNB ASSAY
PROTEOMICS -DTNB ASSAYNidhi Puranik
 
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassayExpt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassayVISHALJADHAV100
 
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassayExpt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassayVISHALJADHAV100
 
Radha_Chafle_303_ALZHEIMER’S DISEASE AND PARKINSON DISEASE.pptx
Radha_Chafle_303_ALZHEIMER’S DISEASE AND PARKINSON DISEASE.pptxRadha_Chafle_303_ALZHEIMER’S DISEASE AND PARKINSON DISEASE.pptx
Radha_Chafle_303_ALZHEIMER’S DISEASE AND PARKINSON DISEASE.pptxRadhaChafle1
 
Expt. 6 Bioassay of histamine using guinea pig ileum by matching method
Expt. 6 Bioassay of histamine using guinea pig ileum by matching methodExpt. 6 Bioassay of histamine using guinea pig ileum by matching method
Expt. 6 Bioassay of histamine using guinea pig ileum by matching methodVISHALJADHAV100
 
Various techniques in molecular bology
Various techniques in molecular bologyVarious techniques in molecular bology
Various techniques in molecular bologyKartikey Singh
 
Hugh Thompson P3 Summer Placement report 2014 (1)
Hugh Thompson P3 Summer Placement report 2014 (1)Hugh Thompson P3 Summer Placement report 2014 (1)
Hugh Thompson P3 Summer Placement report 2014 (1)Hugh E G Thompson
 
Ochratoxin
OchratoxinOchratoxin
Ochratoxinmzk57
 
Validation of Factor IIa for heparin sodium or heparin injection
Validation of Factor IIa for heparin sodium or heparin injectionValidation of Factor IIa for heparin sodium or heparin injection
Validation of Factor IIa for heparin sodium or heparin injectionkrishgen
 
FY-ECH4770 Chicken Total bile acide (TBA) ELISA Kit .pdf
FY-ECH4770 Chicken Total bile acide (TBA) ELISA Kit .pdfFY-ECH4770 Chicken Total bile acide (TBA) ELISA Kit .pdf
FY-ECH4770 Chicken Total bile acide (TBA) ELISA Kit .pdffeiyue lottie
 
Conceição et al, 2006. orpotrin a novel vasoconstrictor peptide from the veno...
Conceição et al, 2006. orpotrin a novel vasoconstrictor peptide from the veno...Conceição et al, 2006. orpotrin a novel vasoconstrictor peptide from the veno...
Conceição et al, 2006. orpotrin a novel vasoconstrictor peptide from the veno...pryloock
 
Validation of factor xa assay for dalteparin sodium dalteparin injection
Validation of factor xa assay for dalteparin sodium dalteparin injectionValidation of factor xa assay for dalteparin sodium dalteparin injection
Validation of factor xa assay for dalteparin sodium dalteparin injectionkrishgen
 
Human S100B(protein S100 B) elisa kit
Human S100B(protein S100 B) elisa kitHuman S100B(protein S100 B) elisa kit
Human S100B(protein S100 B) elisa kitziyiChen18
 
Pyrogen testing 112070804005
Pyrogen testing  112070804005Pyrogen testing  112070804005
Pyrogen testing 112070804005Patel Parth
 

Similar a Screening of anticholinesterases (20)

PROTEOMICS -DTNB ASSAY
PROTEOMICS -DTNB ASSAYPROTEOMICS -DTNB ASSAY
PROTEOMICS -DTNB ASSAY
 
Alzheimer models
Alzheimer modelsAlzheimer models
Alzheimer models
 
project work
project workproject work
project work
 
Lecture 7
Lecture 7Lecture 7
Lecture 7
 
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassayExpt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
 
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassayExpt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
Expt. 1 Bioassay of serotonin using rat fundus strip by three point bioassay
 
Radha_Chafle_303_ALZHEIMER’S DISEASE AND PARKINSON DISEASE.pptx
Radha_Chafle_303_ALZHEIMER’S DISEASE AND PARKINSON DISEASE.pptxRadha_Chafle_303_ALZHEIMER’S DISEASE AND PARKINSON DISEASE.pptx
Radha_Chafle_303_ALZHEIMER’S DISEASE AND PARKINSON DISEASE.pptx
 
Expt. 6 Bioassay of histamine using guinea pig ileum by matching method
Expt. 6 Bioassay of histamine using guinea pig ileum by matching methodExpt. 6 Bioassay of histamine using guinea pig ileum by matching method
Expt. 6 Bioassay of histamine using guinea pig ileum by matching method
 
Various techniques in molecular bology
Various techniques in molecular bologyVarious techniques in molecular bology
Various techniques in molecular bology
 
Anti depressants
Anti depressantsAnti depressants
Anti depressants
 
Hugh Thompson P3 Summer Placement report 2014 (1)
Hugh Thompson P3 Summer Placement report 2014 (1)Hugh Thompson P3 Summer Placement report 2014 (1)
Hugh Thompson P3 Summer Placement report 2014 (1)
 
Ochratoxin
OchratoxinOchratoxin
Ochratoxin
 
DNA Extraction & PCR protocol
DNA Extraction & PCR protocolDNA Extraction & PCR protocol
DNA Extraction & PCR protocol
 
Validation of Factor IIa for heparin sodium or heparin injection
Validation of Factor IIa for heparin sodium or heparin injectionValidation of Factor IIa for heparin sodium or heparin injection
Validation of Factor IIa for heparin sodium or heparin injection
 
FY-ECH4770 Chicken Total bile acide (TBA) ELISA Kit .pdf
FY-ECH4770 Chicken Total bile acide (TBA) ELISA Kit .pdfFY-ECH4770 Chicken Total bile acide (TBA) ELISA Kit .pdf
FY-ECH4770 Chicken Total bile acide (TBA) ELISA Kit .pdf
 
Conceição et al, 2006. orpotrin a novel vasoconstrictor peptide from the veno...
Conceição et al, 2006. orpotrin a novel vasoconstrictor peptide from the veno...Conceição et al, 2006. orpotrin a novel vasoconstrictor peptide from the veno...
Conceição et al, 2006. orpotrin a novel vasoconstrictor peptide from the veno...
 
Validation of factor xa assay for dalteparin sodium dalteparin injection
Validation of factor xa assay for dalteparin sodium dalteparin injectionValidation of factor xa assay for dalteparin sodium dalteparin injection
Validation of factor xa assay for dalteparin sodium dalteparin injection
 
Human S100B(protein S100 B) elisa kit
Human S100B(protein S100 B) elisa kitHuman S100B(protein S100 B) elisa kit
Human S100B(protein S100 B) elisa kit
 
Pyrogen testing 112070804005
Pyrogen testing  112070804005Pyrogen testing  112070804005
Pyrogen testing 112070804005
 
final lab report
final lab reportfinal lab report
final lab report
 

Último

Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...Dr. Asif Anas
 
Work Experience for psp3 portfolio sasha
Work Experience for psp3 portfolio sashaWork Experience for psp3 portfolio sasha
Work Experience for psp3 portfolio sashasashalaycock03
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17Celine George
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 
Department of Health Compounder Question ‍Solution 2022.pdf
Department of Health Compounder Question ‍Solution 2022.pdfDepartment of Health Compounder Question ‍Solution 2022.pdf
Department of Health Compounder Question ‍Solution 2022.pdfMohonDas
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfMohonDas
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17Celine George
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxraviapr7
 
What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?TechSoup
 
Over the counter (OTC)- Sale, rational use.pptx
Over the counter (OTC)- Sale, rational use.pptxOver the counter (OTC)- Sale, rational use.pptx
Over the counter (OTC)- Sale, rational use.pptxraviapr7
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxiammrhaywood
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxAditiChauhan701637
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxraviapr7
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsEugene Lysak
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.raviapr7
 
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptxSlides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptxCapitolTechU
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxDr. Asif Anas
 

Último (20)

Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
Unveiling the Intricacies of Leishmania donovani: Structure, Life Cycle, Path...
 
Work Experience for psp3 portfolio sasha
Work Experience for psp3 portfolio sashaWork Experience for psp3 portfolio sasha
Work Experience for psp3 portfolio sasha
 
Prelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quizPrelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quiz
 
How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17How to Add Existing Field in One2Many Tree View in Odoo 17
How to Add Existing Field in One2Many Tree View in Odoo 17
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 
Department of Health Compounder Question ‍Solution 2022.pdf
Department of Health Compounder Question ‍Solution 2022.pdfDepartment of Health Compounder Question ‍Solution 2022.pdf
Department of Health Compounder Question ‍Solution 2022.pdf
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdf
 
How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17How to Show Error_Warning Messages in Odoo 17
How to Show Error_Warning Messages in Odoo 17
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptx
 
What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?What is the Future of QuickBooks DeskTop?
What is the Future of QuickBooks DeskTop?
 
Over the counter (OTC)- Sale, rational use.pptx
Over the counter (OTC)- Sale, rational use.pptxOver the counter (OTC)- Sale, rational use.pptx
Over the counter (OTC)- Sale, rational use.pptx
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
 
In - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptxIn - Vivo and In - Vitro Correlation.pptx
In - Vivo and In - Vitro Correlation.pptx
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptx
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George Wells
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.
 
Finals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quizFinals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quiz
 
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptxSlides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
Slides CapTechTalks Webinar March 2024 Joshua Sinai.pptx
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptx
 

Screening of anticholinesterases

  • 2. Anti-cholinesterses (anti-Ches) are the agents which  Inhibit ChE.  Protect Ach from hydrolysis.  Produce cholinergic effects in vivo.  Potentiate Ach both in vivo and in vitro. Introduction
  • 5.  In vitro inhibition of acetylcholine-esterase activity in rat striatum  In vitro inhibition of butyrylcholine-esterase activity in human serum  Ex-vivo cholinesterase inhibition  Molecular forms of acetyl-cholinesterase from Rat Frontal Cortex and Striatum  Release of (3H) Ach and other transmitters from Rat Brain Slices  (3H) Oxotremorine –M Binding in the presence and absense of Gpp(NH)p In vitro methods
  • 6.  Stimulation of Phosphatidylinositol Turnover in Rat Brain Slices  (3H) N-Methylcarbamylcholine Binding to Nicotinic Cholinergic Receptors in Rat Frontal Cortex  Uncompetitive NMDA Receptor Antagonism  Secreation of Nerve Growth Factor by Cultured Neurons /Astrogial Cells  Inhibition of RespirTORY Burst in Microglial Cells /Macrophages
  • 7.  Inhibitory Avoidance Methods A. Step down test in mice and rats B. Step through test in rodents C. Uphill avoidance test in rats D. Scopalamine-induced amnesia in mice E. Ibotenic acid-induced impairment of memory  Active Avoidance Tests A. Runway avoidance in rats and mice B. Shuttle box avoidance test(two way shuttle box) C. Jumping avoidance in one-way shuttle box In vivo methods
  • 8.  Discrimination learning A. Spatial habituation learning B. Spatial discrimination test in rodents C. Spatial learning test in the radial arm maze D. Spatial learning test in the water maze E. Olfactory learning in rats  Conditioned response A. Conditioned nictitating membrane response in rabbits
  • 9. In vitro inhibition of acetylcholine-esterase activity on rat striatum Purpose and rationale  The purpose of this assay is to screen drugs for inhibition of acetylcholine-esterase activity.  Inhibitors of this enzyme may be useful for the treatment of Alzheimer’s disease.  PROCEDURE  Reagents:-1) 0.05M,phosphate buffer , PH 7.2  A) 6.85g NaH2PO4.H2O/100ml distilled H2O In vitro methods
  • 10. c) Add a) to b)until pH reaches 7.2 d) Dilute 1:10 2.Substrate in buffer a) 198 mg acetylthiocholine chloride(10mM) b) Q.s.explain to 100ml with 0.05M NaH2PO4,Ph 7.2 3.DTAB in buffer a. 19.8mg 5,5-dithiobisnitrobenzoic acid (DTAB) (0.05mM) b. Q.s. to 100ml with 0.05M NaH2PO4,Ph 7.2 4. A 2mM stock solution of the test drug is made up in a suitable solvent and q.s. to volume with 0.05mM DTAB. Drugs are serially diluted (1:10) such that the final concentration is 10-4M and screened for the activity.
  • 11.  Tissue preparation  Male wistar rats are decapitated , brains rapidly removed,corpora striata dissected free,weighed and homogenized in 19 volumes of 0.05M NaH2PO4,PH 7.2 using a Potter-ELVEJHEM homogeizer.  A 25ul of aliquot of this suspension is added to 1ml of the vehicle or various concentrations of the test drug and reincubated for 10min at 37degree celcius.  Assay  Enzyme activity is measured with the Beckman DU-50 spectrophotometer.  this method can be used for IC50determinations and for measuring kinetic constants.
  • 12.  Reagents are added to the blank and sample cuvettes as follows:-  Blank: 0.8ml PO4 buffer/DTAB  0.8ml buffer/substrate  Control: 0.8ml PO4buffer/DTAB/Enzyme  0.8ml PO4 buffer/substrate  Drug: 0.8ml PO4 buffer/DTAB/Drug/Enzyme  0.8ml PO4buffer/Substrate EVALUATION For IC50 determinations: substrate concentration is 10mM diluted 1:2 in an assay yeilding a final concentrationof 5mM.DTAB concentration yeilding 0.25mM final concentration. %inhibition= slope control-slope drug *100 slope control
  • 13. PURPOSE AND RATIONALE This assay can be used in conjunction with the acetylcholine- esterase assay to determine the enzyme selectivity of various cholinesterase inhibitors. PROCEDURE Reagents 1. 0.05M phosphate buffer,PH 7.2 a) 6.85g NaHPO4.H2O/100ml distilled H2O b) 13.40g NaHPO4.H2O/100ml distilled H2O c) Add (a) to (b) until PH reaches 7.2 d) Dilute 1:10 In vitro inhibition of Butyrylcholine- Esterase Activity in Human serum
  • 14. 2.Substrate in buffer a) 225.8mg s-butyrylthiocholine chloride b) Q.s. to 100ml with 0.05M phosphate buffer,PH 7.2 3.DTAB in buffer a) 19.8mg 5,5-dithiobisnitrobenzoic acid(0.5mM) b) Q.s.to 100ml with 0.05M phosphate buffer,PH 7.2 4. A 2mM stock solution of the test drug is made up in a suitable solvent and q.s. to volume with 0.5mM DTAB. Drugs are serially diluted(1:10) such that determined from the inhibitory activity of subsequent concentrations. Enzyme preparation: A vial of lyophilized human serum is reconstituted in 3ml of distilled water. A 25ml aliquot of this suspension is added to 1ml of the vehicle or various concentrations of the test drug and preincubated for 10min at 37degree cel.
  • 15.  EVALUATION  For IC50 determinations:  Substrate concentration is 10mM diluted 1:2 in assay yeilding final concentration of 5mM.DTAB concentration is 0.5mM yeilding 0.25mM final concentration.  % inhibition = slope control-slope drug *100 slope control
  • 16.  Inhibitory (passive) avoidance • One of the most common animal tests in memory research is the inhibition to initiate activities or learned habits. • “Passive avoidance” is usually employed to describe experiments in which the animal learns to avoid noxious event by suppressing a particular behaviour.  Step-down avoidance Purpose and rational When placed on an elevated platform in the centre of rectangular compartment , it steps down almost immediately to the floor to explore the enclosure and to approach the wall. In vivo methods
  • 17.  PROCEDURE  it consists of three phases  1.familirization  2.learning  3.retention test  EVALUATION  The time of descent During the learning phase And the time during retention test is measured.
  • 18. Step-through method PURPOSE AND RATIONALE When placed into a brightly illuminated space connected to a dark enclosure,they rapidly enter the dark compartment and remain there. PROCEDURE The test animals are placed in The illuminated compartment At a maximal distance from the guillotine door,and the latency to enter in dark comartment is Measured. EVALUATION the time to step through during the learning phase is measured And the time during the retention test is measured.
  • 19.  Drug discovery and evaluation by wolfgang H. Vogel 2nd edition  Screening methods in pharmacology by N.S.Parmar,Shiv Prakash ,4th edition REFERENCES